Walleye Capital
PROK icon

Walleye Capital’s ProKidney PROK Stock Holding History

Walleye Capital’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,678
Closed -$38.6K – 5797
2023
Q4 		$38.6K Buy
+21,678
New +$46.5K ﹤0.01% 4361
2022
Q3 		– Sell
-13,500
Closed -$134K – 3467
2022
Q2 		$134K Sell
13,500
-72,900
-84% -$721K ﹤0.01% 1663
2022
Q1 		$855K Hold
86,400
– – 0.02% 711
2021
Q4 		$855K Hold
86,400
– – 0.03% 686
2021
Q3 		$847 Buy
86,400
+38,400
+80% +$378K 0.02% 545
2021
Q2 		$485 Buy
+48,000
New +$485K 0.02% 759

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Walleye Capital's PROK Position: Q1 2024 in Review

Walleye Capital sold out of ProKidney (PROK) in Q1 2024, closing a stake of 21,678 shares — an estimated $38.6K sold.

Walleye Capital first reported a position in PROK in Q2 2021 and held it in 6 quarters. The position peaked at $855K in Q1 2022. 55 funds tracked by Wall St. Rank hold PROK as of Q1 2024.

  • Walleye Capital reported no remaining ProKidney position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 21,678 ProKidney shares in Q1 2024, an estimated $38.6K.
  • Walleye Capital first reported a position in ProKidney in Q2 2021 and held it in 6 quarters.
  • Walleye Capital's ProKidney position peaked at $855K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held ProKidney as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.